CAS 2449199-61-3
:Emirodatamab
- Research Grade Emirodatamab
- Emirodatamab
- Research Grade Emirodatamab (DHE19101)
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 1 products.
Emirodatamab
CAS:Emirodatamab (AMG-427) is an anti-FLT3/CD3 bispecific T-cell engager with an extended half-life. It can induce high cytotoxicity in primary AML progenitor cells and enhance FLT-3 expression. Combining Emirodatamab with anti-PD-1 antibodies increases T-cell dependent cytotoxicity (TDCC). This compound is under investigation for use in relapsed or refractory AML.
